
Tick-borne encephalitis (TBE) is an emerging public health concern in Sweden, with a steadily increasing incidence over the past two decades. Climate change, expanding tick populations, and increased human exposure contribute to the growing burden of disease. Although TBE vaccination is highly effective,...

It is estimated that two-thirds of TBEV infections in humans are asymptomatic. In symptomatic cases, the first phase of the disease is characterized by flu-like symptoms. In 20–30% of those infected, a second phase develops, potentially leading to meningitis, meningoencephalitis, and other central...

Tick-borne encephalitis (TBE), caused by the TBE virus (TBEV), is a vector-borne neurological disease affecting humans and animals [1]. Transmission predominantly occurs via a bite from an infected Ixodes tick [2] in outdoor and rural environments [3]. TBE is considered endemic in 27 countries...

Tick-borne encephalitis (TBE) is a severe infection of the central nervous system caused by the TBE virus (TBEV), a member of the flavivirus genus, endemic in northeastern Europe and eastern Asia [1]. TBEV can be transmitted by a tick-bite with the highest incidence in the summer months, although transmission...

Tick-borne encephalitis (TBE), which is caused by RNA viruses of the genus flavivirus within the family of the Flaviviridae, is common and one of the most serious neurological tick-transmitted diseases in Central Europe, Eastern Europe, and Russia [1]. Virus can be transmitted through...